Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 424575, 8 pages
http://dx.doi.org/10.1155/2015/424575
Research Article

Kinetics of Circulating Damage-Associated Molecular Patterns in Sepsis

Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan

Received 2 April 2015; Revised 28 May 2015; Accepted 28 May 2015

Academic Editor: Anil Shanker

Copyright © 2015 Takahiro Miki and Toshiaki Iba. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Pierrkos and J.-L. Vincent, “Sepsis biomarkers: a review,” Critical Care, vol. 14, no. 1, article R15, 2010. View at Publisher · View at Google Scholar
  2. A. Van den Bruel, M. J. Thompson, T. Haj-Hassan et al., “Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review,” The British Medical Journal, vol. 342, no. 7810, Article ID d3082, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Oda, H. Hirasawa, H. Shiga et al., “Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis,” Cytokine, vol. 29, no. 4, pp. 169–175, 2005. View at Publisher · View at Google Scholar
  4. I. Herzum and H. Renz, “Inflammatory markers in SIRS, sepsis and septic shock,” Current Medicinal Chemistry, vol. 15, no. 6, pp. 581–587, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Luzzani, E. Polati, R. Dorizzi, A. Rungatscher, R. Pavan, and A. Merlini, “Comparison of procalcitonin and C-reactive protein as markers of sepsis,” Critical Care Medicine, vol. 31, no. 6, pp. 1737–1741, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Denk, M. Perl, and M. Huber-Lang, “Damage- and pathogen-associated molecular patterns and alarmins: keys to sepsis?” European Surgical Research, vol. 48, no. 4, pp. 171–179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Gibot, F. Massin, A. Cravoisy et al., “High-mobility group box 1 protein plasma concentrations during septic shock,” Intensive Care Medicine, vol. 33, no. 8, pp. 1347–1353, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Holdenrieder and P. Stieber, “Clinical use of circulating nucleosomes,” Critical Reviews in Clinical Laboratory Sciences, vol. 46, no. 1, pp. 1–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee, “American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis,” Critical Care Medicine, vol. 20, no. 6, pp. 864–874, 1992. View at Google Scholar
  10. J.-R. Le Gall, S. Lemeshow, and F. Saulnier, “A new simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study,” The Journal of the American Medical Association, vol. 270, no. 24, pp. 2957–2963, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Iba, T. Miki, N. Hashiguchi, Y. Tabe, and I. Nagaoka, “Combination of antithrombin and recombinant thrombomodulin modulates neutrophil cell-death and decreases circulating DAMPs levels in endotoxemic rats,” Thrombosis Research, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. M. M. Levy, R. P. Dellinger, S. R. Townsend et al., “The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis,” Intensive Care Medicine, vol. 36, no. 2, pp. 222–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. R. P. Dellinger, M. M. Levy, A. Rhodes et al., “Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012,” Critical Care Medicine, vol. 41, no. 2, pp. 580–637, 2013. View at Publisher · View at Google Scholar
  14. L. G. Thijs and C. E. Hack, “Time course of cytokine levels in sepsis,” Intensive Care Medicine, vol. 21, supplement 2, pp. S258–S263, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Gibot, A. Cravoisy, M.-N. Kolopp-Sarda et al., “Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis,” Critical Care Medicine, vol. 33, no. 4, pp. 792–796, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Reinhart, W. Karzai, and M. Meisner, “Procalcitonin as a marker of the systemic inflammatory response to infection,” Intensive Care Medicine, vol. 26, no. 9, pp. 1193–1200, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Chen, R. Kang, X. Fan, and D. Tang, “Release and activity of histone in diseases,” Cell Death & Disease, vol. 5, no. 8, Article ID e1370, 2014. View at Publisher · View at Google Scholar
  18. J. Xu, X. Zhang, R. Pelayo et al., “Extracellular histones are major mediators of death in sepsis,” Nature Medicine, vol. 15, no. 11, pp. 1318–1321, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Semeraro, C. T. Ammollo, J. H. Morrissey et al., “Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4,” Blood, vol. 118, no. 7, pp. 1952–1961, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Nakahara, T. Ito, K. Kawahara et al., “Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism,” PLoS ONE, vol. 8, no. 9, Article ID e75961, 2013. View at Publisher · View at Google Scholar
  21. M. Ekaney, G. Otto, M. Sossdorf et al., “Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation,” Critical Care, vol. 18, no. 5, article 543, 2014. View at Publisher · View at Google Scholar
  22. S. Zeerleder, B. Zwart, W. A. Wuillemin et al., “Elevated nucleosome levels in systemic inflammation and sepsis,” Critical Care Medicine, vol. 31, no. 7, pp. 1947–1951, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. Q. Chen, L. Ye, Y. Jin et al., “Circulating nucleosomes as a predictor of sepsis and organ dysfunction in critically ill patients,” International Journal of Infectious Diseases, vol. 16, no. 7, pp. e558–e564, 2012. View at Publisher · View at Google Scholar · View at Scopus